ACM
BSX icon

Aubrey Capital Management’s Boston Scientific BSX Stock Holding History

Aubrey Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,000
Closed -$4.73M – 54
2025
Q2 		$4.73M Hold
44,000
– – 1.72% 18
2025
Q1 		$4.44M Sell
44,000
-6,600
-13% -$665K 1.78% 12
2024
Q4 		$4.52M Buy
50,600
+1,400
+3% +$123K 1.71% 14
2024
Q3 		$4.12M Buy
49,200
+1,600
+3% +$126K 1.59% 18
2024
Q2 		$3.19M Buy
+47,600
New +$3.48M 1.27% 24

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aubrey Capital Management's BSX Position: Q3 2025 in Review

Aubrey Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 44,000 shares — an estimated $4.73M sold.

Aubrey Capital Management first reported a position in BSX in Q2 2024 and held it in 5 quarters. The position peaked at $4.73M in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Aubrey Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Aubrey Capital Management sold 44,000 Boston Scientific shares in Q3 2025, an estimated $4.73M.
  • Aubrey Capital Management first reported a position in Boston Scientific in Q2 2024 and held it in 5 quarters.
  • Aubrey Capital Management's Boston Scientific position peaked at $4.73M in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Aubrey Capital Management's 13F filing for Q3 2025, filed 30 Oct 2025.